Method of treating traumatic brain injury with red/NIR light
US-10561857-B2 · Feb 18, 2020 · US
Trans-orbital infrared light therapy
US10960224B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10960224-B2 |
| Application number | US-201715839954-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 13, 2017 |
| Priority date | Jan 12, 2017 |
| Publication date | Mar 30, 2021 |
| Grant date | Mar 30, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A device adapted to deliver red/NIR light through an eyelid of a patient, the device comprising: a) a nose bridge, b) a first orbital rim adapted to encircle a first eye, wherein the first orbital rim is attached to the bridge, and c) a red/NIR LED attached to the rim.
First claim
Opening claim text (preview).
We claim: 1. A method comprising: a) placing a light-emitting portion of a device comprising a near infrared LED against an eyelid of a patient having a brain disorder in a location between an upper portion of an eye and a corresponding eye socket of the patient, b) moving the device posteriorly so that at least a portion thereof sits within a portion of an outer region of the eye socket, and c) actuating the LED to deliver near infrared light to an orbitofrontal cortex of the patient. 2. The method of claim 1 wherein the light is emitted on a side of the device opposing the eye. 3. The method of claim 1 wherein the light-emitting portion comprises a proximal near infrared LED and a distal light transmitting portion. 4. The method of claim 1 wherein the device has a distal end portion that is substantially concavo-convex. 5. The method of claim 1 wherein the device further comprises electronics adapted to provide a substantially constant current. 6. The method of claim 1 wherein the device is carried on a mask. 7. The method of claim 1 wherein the LED is carried on a hinge.
Assignees
Inventors
Classifications
Visible light · CPC title
the light being directed to the eyes · CPC title
Coloured light · CPC title
Diodes · CPC title
- A61N5/0622Primary
Optical stimulation for exciting neural tissue · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10960224B2 cover?
- A device adapted to deliver red/NIR light through an eyelid of a patient, the device comprising: a) a nose bridge, b) a first orbital rim adapted to encircle a first eye, wherein the first orbital rim is attached to the bridge, and c) a red/NIR LED attached to the rim.
- Who is the assignee on this patent?
- Janssen Pharmaceutica Nv
- What technology area does this patent fall under?
- Primary CPC classification A61N5/0622. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).